
590-S (1-phthalidyl-5-fluorouracil) is a derivative of 5-fluorouracil and shows a several characteristics in experimental studies. That is, good absorption from the intestine, high blood levels of 5-fluorouracil, its rapid clearance, low toxicities, excellent tumor inhibition and broad anticancer spectrum, etc. From preliminary studies and phase I studies, MTD is thought to be 750-800 mg/m2 in daily administration. Mild G.I. toxicities was encountered in a few cases. However, CNS toxicities were not experienced in any of our cases.
Adult, Male, Leukemia, Experimental, Administration, Oral, Antineoplastic Agents, Nausea, Neoplasms, Experimental, Middle Aged, Drug Administration Schedule, Anorexia, Rats, Mice, Liver Neoplasms, Experimental, Animals, Drug Evaluation, Humans, Female, Fluorouracil, Rabbits, Sarcoma, Experimental
Adult, Male, Leukemia, Experimental, Administration, Oral, Antineoplastic Agents, Nausea, Neoplasms, Experimental, Middle Aged, Drug Administration Schedule, Anorexia, Rats, Mice, Liver Neoplasms, Experimental, Animals, Drug Evaluation, Humans, Female, Fluorouracil, Rabbits, Sarcoma, Experimental
| citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
